Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 53

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Cell Transplantation with Sequential-Based Conditioning in Refractory / Relapsed Acute Myeloid Leukemia: Experience from a Single Institution

Blood (2023) 142 (Supplement 1): 3550.

https://doi.org/10.1182/blood-2023-179852

Published: 2023

Journal Articles

Evaluation of the Use of Post-Transplant Cyclophosphamide in Patients Diagnosed of Myelodysplastic Syndrome Who Undergo Allogenic Hematopoietic Cell Transplantation

Blood (2023) 142 (Supplement 1): 7018.

https://doi.org/10.1182/blood-2023-181076

Published: 2023

Journal Articles

Post-Transplant Cyclophosphamide-Based Prophylaxis and Its Impact on the Immune Reconstitution and the Incidence of Infectious Complications

Blood (2023) 142 (Supplement 1): 2200.

https://doi.org/10.1182/blood-2023-186687

Published: 2023

Journal Articles

Easix Application in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Prophylaxis

Blood (2022) 140 (Supplement 1): 7616–7618.

https://doi.org/10.1182/blood-2022-167051

Published: 2022

Journal Articles

Impact of Ptcy-Based Prophylaxis on Early Infectious Complications in Adults Undergoing Peripheral Blood Allo-HCT

Blood (2022) 140 (Supplement 1): 4730–4732.

https://doi.org/10.1182/blood-2022-170498

Published: 2022

Journal Articles

Impressive Reduction of Gvhd Incidence Using Ptcy-TK for Gvhd Prevention in Adults Undergoing 10/10 HLA-Matched Peripheral Blood Allo-HCT

María Queralt Salas, Paola Charry, Nuria Martínez-Cibrian, María Suárez-Lledó, Luis Gerardo Rodríguez-Lobato, Marc Brusosa, María Teresa Solano, Meritxell Nomdedeu, Joan Cid, Miquel Lozano, Jordi Arcarons, Noemí Llobet, Laura Rosinol Dachs, Jordi Esteve, Álvaro Urbano-Ispizua, Enric Carreras, Francesc Fernández-Avilés, Maria Carmen Martinez Munoz, Montserrat Rovira

Blood (2022) 140 (Supplement 1): 4772–4773.

https://doi.org/10.1182/blood-2022-170407

Published: 2022

Journal Articles

Endotheliopathy, Innate-Immune Activation and Hemostatic Misbalance Underlying CAR-T Cell Toxicities: Tools for Early and Differential Diagnosis

Ana Belén Moreno-Castaño, Sara Fernandez, Marta Palomo, Julia Martinez-Sanchez, Alex Ramos, Patricia Molina, Marc Pino, Valentín Ortiz-Maldonado, Julio Delgado, Carlos Fernández De Larrea, Álvaro Urbano-Ispizua, Gines Escolar, Enric Carreras, Francesc Fernández-Avilés, Pedro Castro, Maribel Diaz-Ricart

Blood (2022) 140 (Supplement 1): 7427–7428.

https://doi.org/10.1182/blood-2022-169293

Published: 2022

Journal Articles

Improved GvHD-Free, Relapse-Free Survival (GRFS) with Post-Transplant Cyclophosphamide and Tacrolimus for GvHD Prevention in Older Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

Paola Andrea Charry, Maria Queralt Salas, Alexandra Pedraza, María Suárez-Lledó, Nuria Martínez-Cibrian, Teresa Solano, Ariadna Domenech, Meritxell Nomdedeu, Joan Cid, Miquel Lozano, Laura Rosinol, Francesc Fernández-Avilés, Gonzalo Gutiérrez-García, Enric Carreras, Jordi Esteve, Álvaro Urbano-Ispizua, Montserrat Rovira, Carmen Martínez

Blood (2021) 138 (Supplement 1): 2760.

https://doi.org/10.1182/blood-2021-153366

Published: 2021

Journal Articles

Validation of Different Prognostic Scores in Allogeneic Hematopoietic Cell Transplantation in the Post-Transplant Cyclophosphamide Era

Blood (2021) 138 (Supplement 1): 3925.

https://doi.org/10.1182/blood-2021-153069

Published: 2021

Journal Articles

Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group

Blood (2020) 136 (Supplement 1): 6–8.

https://doi.org/10.1182/blood-2020-141872

Published: 2020

Journal Articles

Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty

Ana Belen Moreno-Castaño, MD PhDStudent, Sara Fernandez, MD, Marta Palomo, PhD, Patricia Molina, Technician, Julia Martinez-Sanchez, PhDStudent, Sergi Torramade-Moix, PhDStudent, Helena Ventosa, MD, Ferran Segui, MD, Gines Escolar, MD PhD, Enric Carreras, MD PhD, Jose Maria Nicolas, MD PhD, Edward Richardson, MD, David Garcia-Bernal, PhD, Carmelo Carlo-Stella, MD, Jose Maria Moraleda, MD PhD, Paul G. Richardson, MD, Maribel Diaz-Ricart, Pedro Castro, MD PhD

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-142311

Published: 2020

Journal Articles

Underdiagnosed Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome(VOD/SOS) As a Major Cause of Multi-Organ Failure in Acute Leukemia Transplant Patients: An Analysis from the EBMT Acute Leukemia Working Party

Blood (2019) 134 (Supplement_1): 4483.

https://doi.org/10.1182/blood-2019-124065

Published: 2019

Journal Articles

A Pooled Analysis of Survival By Defibrotide Timing of Initiation in Adults with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Following Hematopoietic Stem Cell Transplant (HSCT)

Paul Richardson, Enric Carreras, Antonio Pagliuca, Robert Ryan, William Tappe, Mohamad Mohty, MD PhD

Blood (2018) 132 (Supplement 1): 815.

https://doi.org/10.1182/blood-2018-99-113099

Published: 2018

Journal Articles

What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance

Marta Palomo, Enrique Mir, Montse Rovira, Ginés Escolar, Enric Carreras, Maribel Diaz-Ricart

Blood (2016) 127 (13): 1719–1727.

https://doi.org/10.1182/blood-2015-10-676114

Published: 2016

Includes: Multimedia, Supplemental data

Journal Articles

Feasibility and Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation in High-Risk AML: Real-Life Perspective from a Single Institution

Marina Diaz-Beya, MD PhD, Miguel Angel Torrente, Alfonso Ardilla, Carles Serra, Nuria Martinez, Maria Suarez-Lledo, Carmen Martinez, Francesc Fernandez, Laura Rosiñol, Gonzalo Gutierrez, Pedro Marin, Marta Pratcorona, Nuria Mariegues, Noemi Llobet, Marta Bistagne, Enric Carreras, Alvaro Urbano-Ispizua, Montserrat Rovira, Jordi Esteve, MD PhD

Blood (2015) 126 (23): 4395.

https://doi.org/10.1182/blood.V126.23.4395.4395

Published: 2015

Journal Articles

Evidence of Defibrotide Internalization and Its Protective Effect in a Hepatic Endothelial in Vitro model

Maribel Diaz-Ricart, PhD, Marta Palomo, PhD, Enric Mir, PhD, Montserrat Rovira, MD PhD, Gines Escolar, MD PhD, Enric Carreras, MD PhD

Blood (2014) 124 (21): 5960.

https://doi.org/10.1182/blood.V124.21.5960.5960

Published: 2014

Journal Articles

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation

Christen L Mumaw, BS, Ayman Akil, PhD, Nieves Velez de Mendizabal, PhD, Qing Zhang, Nisha Raiker, BS, Jeffrey Yu, Maribel Diaz-Ricart, PhD, Enric Carreras, MD, Laura S. Haneline, MD, Kent A. Robertson, MD PhD, Lindsey Elmore, Rose Case, Jamie Renbarger, MD, Samir Hanash, MD PhD, Robert R. Bies, PhD, Sophie Paczesny, MD PhD

Blood (2014) 124 (21): 663.

https://doi.org/10.1182/blood.V124.21.663.663

Published: 2014

Journal Articles

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients

Selim Corbacioglu, MD, Enric Carreras, MD PhD, Mohamad Mohty, MD PhD, Antonio Pagliuca, MD FRCP, FRCPath, Maria Ballabio, MD, Robin L. Hume, MS, Valeria Bandiera, Giorgia Finetto, Paul G. Richardson

Blood (2014) 124 (21): 1138.

https://doi.org/10.1182/blood.V124.21.1138.1138

Published: 2014

Journal Articles

Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation

Damien Roos-Weil, Sascha Dietrich, Ariane Boumendil, Emmanuelle Polge, Dominique Bron, Enric Carreras, Arturo Iriondo Atienza, William Arcese, Dietrich W. Beelen, Jan J. Cornelissen, Nicolaus Kröger, Giuseppe Milone, Giuseppe Rossi, Fabrice Jardin, Christina Peters, Vanderson Rocha, Anna Sureda, Mohamad Mohty, Peter Dreger

Blood (2013) 121 (3): 440–446.

https://doi.org/10.1182/blood-2012-08-448613

Published: 2013

Includes: Supplemental data

Journal Articles

The Combination of the EBMT Score and the HCT-CI Is Not Better Than the HCT-CI Alone in the Prediction of NRM and OS in Patients Undergoing Allogeneic Hematopoietic Transplantation with Reduced-Toxicity Conditioning

Pere Barba, David Valcarcel, MD, Lucía López-Corral, MD, Francesc fernandez-Aviles, Rodrigo Martino, MD, PhD, Monica Cabrero, Montserrat Rovira, jose Luis Pinana, Salut Brunet, Enric Carreras, MD, PhD, maria Dolores Caballero, Jorge Sierra, MD

Blood (2012) 120 (21): 1925.

https://doi.org/10.1182/blood.V120.21.1925.1925

Published: 2012

NARROW

Allogeneic Hematopoietic Cell Transplantation with Sequential-Based Conditioning in Refractory / Relapsed Acute Myeloid Leukemia: Experience from a Single Institution

Evaluation of the Use of Post-Transplant Cyclophosphamide in Patients Diagnosed of Myelodysplastic Syndrome Who Undergo Allogenic Hematopoietic Cell Transplantation

Post-Transplant Cyclophosphamide-Based Prophylaxis and Its Impact on the Immune Reconstitution and the Incidence of Infectious Complications

Easix Application in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Prophylaxis

Impact of Ptcy-Based Prophylaxis on Early Infectious Complications in Adults Undergoing Peripheral Blood Allo-HCT

Impressive Reduction of Gvhd Incidence Using Ptcy-TK for Gvhd Prevention in Adults Undergoing 10/10 HLA-Matched Peripheral Blood Allo-HCT

Endotheliopathy, Innate-Immune Activation and Hemostatic Misbalance Underlying CAR-T Cell Toxicities: Tools for Early and Differential Diagnosis

Improved GvHD-Free, Relapse-Free Survival (GRFS) with Post-Transplant Cyclophosphamide and Tacrolimus for GvHD Prevention in Older Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

Validation of Different Prognostic Scores in Allogeneic Hematopoietic Cell Transplantation in the Post-Transplant Cyclophosphamide Era

Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group

Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty

Underdiagnosed Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome(VOD/SOS) As a Major Cause of Multi-Organ Failure in Acute Leukemia Transplant Patients: An Analysis from the EBMT Acute Leukemia Working Party

A Pooled Analysis of Survival By Defibrotide Timing of Initiation in Adults with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Following Hematopoietic Stem Cell Transplant (HSCT)

What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance

Feasibility and Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation in High-Risk AML: Real-Life Perspective from a Single Institution

Evidence of Defibrotide Internalization and Its Protective Effect in a Hepatic Endothelial in Vitro model

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients

Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation

The Combination of the EBMT Score and the HCT-CI Is Not Better Than the HCT-CI Alone in the Prediction of NRM and OS in Patients Undergoing Allogeneic Hematopoietic Transplantation with Reduced-Toxicity Conditioning

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only